(Q37127462)

18 August 2017

1 reference

title

SSRI adverse events: how to monitor and manage (English)

1 reference

18 August 2017

3

Eric A Storch

1 reference

18 August 2017

1

Tanya K Murphy

1 reference

18 August 2017

4

Wayne K Goodman

1 reference

18 August 2017

Ana Segarra

2

1 reference

18 August 2017

language of work or name

1 reference

1 April 2008

1 reference

International Review of Psychiatry

18 August 2017

published in

1 reference

18 August 2017

volume

20

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

203-208

1 reference

A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Some aspects of genetic polymorphism in the biotransformation of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Early onset bipolar disorder: clinical and research considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Review of the efficacy and safety of antidepressants in youth depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Risk of adverse behavioral effects with pediatric use of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Selective serotonin reuptake inhibitor-induced apathy: a pediatric case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Complications of SSRI treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Decreased growth during therapy with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Impact of depression and its treatment on the bones of growing children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801889211

10.1080/09540260801889211

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference